Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB26FR1QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,605
Award facts
- Contract value 100% obligated
- $29,604.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,604.63 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price contract, issued on October 30, 2025, with completion targeted for October 31, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award involved no set-aside designation, indicating competitive selection among qualified vendors. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the same location designated as the place of performance—is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and specialized medical devices. Repatha, a PCSK9 inhibitor used for cardiovascular disease management, represents the type of specialized pharmaceutical commodity the company routinely provides through this contract vehicle to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FR1QN?
SPE2DB26FR1QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FR1QN worth?
The government has obligated $29,605 on SPE2DB26FR1QN.
Is contract SPE2DB26FR1QN an order under another contract?
Yes. SPE2DB26FR1QN is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB26FR1QN competed?
The extent of competition for SPE2DB26FR1QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award